The BostonGene Tumor Portrait™ test integrates genomic (WES) and transcriptomic (RNA-seq) analyses of tumors and the tumor microenvironment in the single report to reveal key drivers of each tumor, including:
- Immune microenvironment properties
- Actionable mutations
- Biomarkers of response to diverse therapies
- Therapy options
After a comprehensive analysis, the BostonGene Tumor Portrait™ test generates a personalized roadmap for therapeutic decision-making for individual cancer patients.